Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02773446 · ClinicalTrials.gov registry record · NA
Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT02773446 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 47 participants.
The verdict
NCT02773446, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safe and optimal dose and regimen (fasting duration) for administering the challenge ETEC strain B7A, a CS6 expressing ETEC strain. Additionally, an assessment of homologous protection following rechallenge with B7A will be assessed.
Interventions
- BIOLOGICAL ETEC strain B7A (O148:H28 CS6+ LT+ST+) (Lot 0481) in Buffer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02773446
The ClinicalTrials.gov registry entry for NCT02773446 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ETEC strain B7A (O148:H28 CS6+ LT+ST+) (Lot 0481) in Buffer is the first listed.
NCT02773446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02773446 about?
NCT02773446 is a clinical study titled "Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A". The purpose of this study is to determine the safe and optimal dose and regimen (fasting duration) for administering the challenge ETEC strain B7A, a CS6 expressing ETEC strain. Additionally, an assessment of homologous protection following rechallenge with B7A will be assessed.
What is the current status of trial NCT02773446?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2016-04. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02773446?
The interventions under investigation include: ETEC strain B7A (O148:H28 CS6+ LT+ST+) (Lot 0481) in Buffer (BIOLOGICAL).
Who is sponsoring clinical trial NCT02773446?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.